scispace - formally typeset
S

Steffen Desch

Researcher at Leipzig University

Publications -  302
Citations -  14538

Steffen Desch is an academic researcher from Leipzig University. The author has contributed to research in topics: Myocardial infarction & Percutaneous coronary intervention. The author has an hindex of 48, co-authored 264 publications receiving 11318 citations. Previous affiliations of Steffen Desch include University of Lübeck.

Papers
More filters
Journal ArticleDOI

Prognostic impact of atrial fibrillation in cardiogenic shock complicating acute myocardial infarction: a substudy of the IABP-SHOCK II trial.

TL;DR: AF is not associated with clinical outcome at 30 days and 12 months in CS complicating AMI and there was no interaction of intraaortic balloon counterpulsation (IABP) and no IABP in patients with or without AF with respect to clinical outcome.
Journal ArticleDOI

Catalytic iron in acute myocardial infarction complicated by cardiogenic shock - A biomarker substudy of the IABP-SHOCK II-trial.

TL;DR: Catalytic iron levels were associated with increased short-term mortality in CS complicating acute myocardial infarction and predictors of high CI levels on day 3 were baseline CI, bleeding events, and baseline troponin T.
Journal ArticleDOI

Impact of Atrial Fibrillation During ST-Segment-Elevation Myocardial Infarction on Infarct Characteristics and Prognosis.

TL;DR: In this article, the authors investigated the relationship of the presence of atrial fibrillation (AF) to cardiac magnetic resonance (CMR) derived myocardial salvage and damage as well as clinical outcomes.
Journal ArticleDOI

Correction to: Prognostic impact of baseline glucose levels in acute myocardial infarction complicated by cardiogenic shock-a substudy of the IABP-SHOCK II-trial.

TL;DR: The title of this article was rendered incorrectly; the correct title is as follows; the complete list of winners and runners-up in the 2016 Rio Olympics is revealed.
Journal ArticleDOI

Stents liberadores de rapamicina sin polímero frente a stents liberadores de paclitaxel con polímero: un análisis de datos de pacientes procedentes de ensayos aleatorizados

TL;DR: En nuestro estudio se compararon las medidas de eficacia angiograficas y clinicas de los stents liberadores de rapamicina sin polimero frente a los freeadores of paclitaxel con polimeros y asociaron con similares riesgos de muerte o infarto de miocardio.